Opening https://www.businesswire.com/news/home/20230310005415/en/Innoviva-Announces-FDA-Advisory-Committee-Meeting-to-Review-Sulbactam-Durlobactam-SUL-DUR-an-Investigational-Targeted-Antibiotic